Dan Hirschfeld
August 1, 2025Advertisement
Implantcast, a leading German manufacturer of high-tech prosthetics, is grappling with new US tariffs that impose a 15% duty on imports. Despite strong demand and proven product quality, Managing Director Florian Hoffmann warns of planning difficulties and competitive disadvantages. With limited cost-cutting options, the company aims to offset price hikes through innovation, especially in its advanced tumor prostheses that grow with patients — products valued even beyond tariff concerns.
(This video summary was created using AI. A journalist edited it before publication.)